Cargando…

5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma

Gliomas typically have unfavorable prognosis, due to late detection and interventions. However, effective biomarkers for early glioma diagnosis based on 5-hydroxymethylcytosines (5 hm C) in circulating cell-free DNA (cfDNA) are not currently available. 5 hm C profiles in GSE132118 set were subjected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chunyu, Zhou, Wei, Tan, Yinqiu, Tian, Daofeng, Zhong, Chunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587273/ https://www.ncbi.nlm.nih.gov/pubmed/36281400 http://dx.doi.org/10.1016/j.heliyon.2022.e11022

Ejemplares similares

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
por: Li, Wenshuai, et al.
Publicado: (2017)

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease
por: Dong, Chaoran, et al.
Publicado: (2020)

An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas
por: Cai, Jiajun, et al.
Publicado: (2021)

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
por: Zhang, Chunyu, et al.
Publicado: (2022)

5‐Hydroxymethylcytosine signature in circulating cell‐free DNA as a potential diagnostic factor for early‐stage colorectal cancer and precancerous adenoma
por: Xiao, ZeWen, et al.
Publicado: (2020)

5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Early Warning Biomarkers for COVID-19 Progression and Myocardial Injury
por: Chen, Hang-yu, et al.
Publicado: (2022)

ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)

Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma
por: Chiu, Brian C.-H., et al.
Publicado: (2022)

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
por: Guler, Gulfem D., et al.
Publicado: (2020)

Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine
por: Shao, Jianming, et al.
Publicado: (2023)

5‐Hydroxymethylcytosine profiling from genomic and cell‐free DNA for colorectal cancers patients
por: Gao, Pingting, et al.
Publicado: (2019)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia
por: Shao, Jianming, et al.
Publicado: (2022)

Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma
por: Cai, Z., et al.
Publicado: (2021)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
por: Song, Chun-Xiao, et al.
Publicado: (2017)

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
por: Cai, Jiabin, et al.
Publicado: (2019)

Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA
por: Szwagierczak, Aleksandra, et al.
Publicado: (2010)

Characterization of the 5-hydroxymethylcytosine-specific DNA restriction endonucleases
por: Borgaro, Janine G., et al.
Publicado: (2013)

5-Hydroxymethylcytosine Is Not Present in Appreciable Quantities in Arabidopsis DNA
por: Erdmann, Robert M., et al.
Publicado: (2014)

Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia
por: Shao, Jianming, et al.
Publicado: (2023)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Notch signaling genes: Myogenic DNA hypomethylation and 5-hydroxymethylcytosine
por: Terragni, Jolyon, et al.
Publicado: (2014)

Bisulfite-free, single base-resolution analysis of 5-hydroxymethylcytosine in genomic DNA by chemical-mediated mismatch
por: Wang, Yafen, et al.
Publicado: (2018)

5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease
por: Chu, Jin-Lin, et al.
Publicado: (2022)

5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma
por: Tong, Mengying, et al.
Publicado: (2019)

Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer
por: Hu, Xinlei, et al.
Publicado: (2022)

Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers
por: Wang, Zhihui, et al.
Publicado: (2020)

Bisulfite-free and single-nucleotide resolution sequencing of DNA epigenetic modification of 5-hydroxymethylcytosine using engineered deaminase
por: Xie, Neng-Bin, et al.
Publicado: (2022)

Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA
por: Fu, Lijuan, et al.
Publicado: (2014)

5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
por: Uribe-Lewis, Santiago, et al.
Publicado: (2015)

5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA
por: Tomkova, Marketa, et al.
Publicado: (2016)

The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing
por: Huang, Yun, et al.
Publicado: (2010)

Alterations of 5-Hydroxymethylcytosine in Human Cancers
por: Mariani, Christopher J., et al.
Publicado: (2013)

Formation and Abundance of 5-Hydroxymethylcytosine in RNA
por: Huber, Sabrina M, et al.
Publicado: (2015)

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021)

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
por: Sjöström, Martin, et al.
Publicado: (2022)

Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma
por: Ahsan, Sama, et al.
Publicado: (2014)

Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine
por: Jin, Seung-Gi, et al.
Publicado: (2010)

Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
por: Orr, Brent A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ohkbj47ps63l0cl1a7ip8kk9cq